Parallel Advisors, LLC Nuvation Bio Inc. Transaction History
Parallel Advisors, LLC
- $4.31 Billion
- Q1 2025
A detailed history of Parallel Advisors, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 5,092 shares of NUVB stock, worth $9,267. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,092Holding current value
$9,267% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding NUVB
# of Institutions
165Shares Held
150MCall Options Held
1.2KPut Options Held
223K-
Decheng Capital LLC Menlo Park, CA26MShares$47.2 Million14.81% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$29.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$28.6 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$23.8 Million53.05% of portfolio
-
Octagon Capital Advisors LP New York, NY9.2MShares$16.7 Million5.46% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $395M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...